发明名称 |
METHOD FOR DETERMINING BREAST CANCER TREATMENT |
摘要 |
The present invention provides a method for determining a treatment procedure for breast cancer, a method of predicting a likelihood of success in treating breast cancer, and a method for selecting an endocrine therapy agent for treating breast cancer. In particular, methods of the present invention rely on the amount of androgen receptor (AR) and estrogen receptor (ER) in a tissue sample. |
申请公布号 |
US2015253329(A1) |
申请公布日期 |
2015.09.10 |
申请号 |
US201314423133 |
申请日期 |
2013.03.15 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
发明人 |
Mouchantat Jennifer Richer |
分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for predicting a likelihood of responding positively to an endocrine therapy of a breast cancer patient comprising:
determining the amount of androgen receptor (AR) and estrogen receptor (ER) present in a tissue sample of the patient; and comparing the amount of AR and ER in the tissue sample; wherein a positive correlation between AR and ER is indicative of a likelihood of a positive response to an anti-estrogen endocrine therapy. |
地址 |
Denver CO US |